Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Overview

NASDAQ:BWAY - US10501L1061 - ADR

15.56 USD
+0.22 (+1.43%)
Last: 8/29/2025, 8:09:21 PM

BWAY Key Statistics, Chart & Performance

Key Statistics
52 Week High16
52 Week Low7.06
Market Cap294.11M
Shares18.90M
Float15.75M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)1.39
PE11.19
Fwd PE7.7
Earnings (Next)11-10 2025-11-10/bmo
IPO12-24 2006-12-24
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


BWAY short term performance overview.The bars show the price performance of BWAY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

BWAY long term performance overview.The bars show the price performance of BWAY in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of BWAY is 15.56 USD. In the past month the price increased by 35.66%. In the past year, price increased by 96.71%.

BRAINSWAY LTD-ADR / BWAY Daily stock chart

BWAY Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.07 230.89B
ISRG INTUITIVE SURGICAL INC 58.79 169.67B
BSX BOSTON SCIENTIFIC CORP 37.28 156.32B
SYK STRYKER CORP 30.46 149.64B
MDT MEDTRONIC PLC 16.78 119.05B
BDX BECTON DICKINSON AND CO 13.52 55.31B
IDXX IDEXX LABORATORIES INC 53.88 51.77B
EW EDWARDS LIFESCIENCES CORP 31.65 47.75B
RMD RESMED INC 28.74 40.19B
GEHC GE HEALTHCARE TECHNOLOGY 15.82 33.66B
DXCM DEXCOM INC 44.32 29.55B
PHG KONINKLIJKE PHILIPS NVR- NY 16.42 26.56B

About BWAY

Company Profile

BWAY logo image Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Company Info

BRAINSWAY LTD-ADR

16 Hartum Street Rad Tower, 14Th Floor, Har HaHotzvim

JERUSALEM 9777518 IL

CEO: Christopher R. von Jako

Employees: 120

BWAY Company Website

BWAY Investor Relations

Phone: 97225813140

BRAINSWAY LTD-ADR / BWAY FAQ

What is the stock price of BRAINSWAY LTD-ADR today?

The current stock price of BWAY is 15.56 USD. The price increased by 1.43% in the last trading session.


What is the ticker symbol for BRAINSWAY LTD-ADR stock?

The exchange symbol of BRAINSWAY LTD-ADR is BWAY and it is listed on the Nasdaq exchange.


On which exchange is BWAY stock listed?

BWAY stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BRAINSWAY LTD-ADR stock?

7 analysts have analysed BWAY and the average price target is 0.1 USD. This implies a price decrease of -99.38% is expected in the next year compared to the current price of 15.56. Check the BRAINSWAY LTD-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BRAINSWAY LTD-ADR worth?

BRAINSWAY LTD-ADR (BWAY) has a market capitalization of 294.11M USD. This makes BWAY a Micro Cap stock.


How many employees does BRAINSWAY LTD-ADR have?

BRAINSWAY LTD-ADR (BWAY) currently has 120 employees.


What are the support and resistance levels for BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a support level at 12.62. Check the full technical report for a detailed analysis of BWAY support and resistance levels.


Is BRAINSWAY LTD-ADR (BWAY) expected to grow?

The Revenue of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 16.02% in the next year. Check the estimates tab for more information on the BWAY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BRAINSWAY LTD-ADR (BWAY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BRAINSWAY LTD-ADR (BWAY) stock pay dividends?

BWAY does not pay a dividend.


When does BRAINSWAY LTD-ADR (BWAY) report earnings?

BRAINSWAY LTD-ADR (BWAY) will report earnings on 2025-11-10, before the market open.


What is the Price/Earnings (PE) ratio of BRAINSWAY LTD-ADR (BWAY)?

The PE ratio for BRAINSWAY LTD-ADR (BWAY) is 11.19. This is based on the reported non-GAAP earnings per share of 1.39 and the current share price of 15.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for BWAY.


What is the Short Interest ratio of BRAINSWAY LTD-ADR (BWAY) stock?

The outstanding short interest for BRAINSWAY LTD-ADR (BWAY) is 0.52% of its float. Check the ownership tab for more information on the BWAY short interest.


BWAY Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 95.02% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BWAY Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BWAY. While BWAY has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BWAY Financial Highlights

Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 1.39. The EPS increased by 1178.38% compared to the year before.


Industry RankSector Rank
PM (TTM) 9.01%
ROA 3.91%
ROE 6.14%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%141.89%
Sales Q2Q%21.26%
EPS 1Y (TTM)1178.38%
Revenue 1Y (TTM)29.04%

BWAY Forecast & Estimates

7 analysts have analysed BWAY and the average price target is 0.1 USD. This implies a price decrease of -99.38% is expected in the next year compared to the current price of 15.56.

For the next year, analysts expect an EPS growth of 58.83% and a revenue growth 16.02% for BWAY


Analysts
Analysts85.71
Price Target0.1 (-99.36%)
EPS Next Y58.83%
Revenue Next Year16.02%

BWAY Ownership

Ownership
Inst Owners5.19%
Ins Owners16.69%
Short Float %0.52%
Short Ratio1.39